ResearcherKitasato University HospitalActive in the last 2 years

Nobuyuki Nishizawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-1863-3060; OpenAlex author ID A5052584235. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. Co-author DOI 10.1007/s13691-024-00715-0 ↗
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. Co-author DOI 10.1111/cas.14134 ↗
Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K-ras gene mutation in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.9839 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yusuke Kumamoto · 3 shared papers, 2019–2024 · strength 0.37
Kosuke Okuwaki · 2 shared papers, 2019–2024 · strength 0.29
- Paper High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. DOI 10.1007/s13691-024-00715-0 ↗
- Paper Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. DOI 10.1111/cas.14134 ↗
Chika Kusano · 1 shared paper, 2024 · strength 0.21
- Paper High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. DOI 10.1007/s13691-024-00715-0 ↗
Masafumi Watanabe · 1 shared paper, 2024 · strength 0.21
- Paper High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. DOI 10.1007/s13691-024-00715-0 ↗
Kai Adachi · 1 shared paper, 2024 · strength 0.21
- Paper High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. DOI 10.1007/s13691-024-00715-0 ↗
Taro Hanaoka · 1 shared paper, 2024 · strength 0.21
- Paper High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. DOI 10.1007/s13691-024-00715-0 ↗
Keishi Yamashita · 2 shared papers, 2019 · strength 0.16
- Paper Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. DOI 10.1111/cas.14134 ↗
- Paper Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K-ras gene mutation in … DOI 10.3892/ol.2018.9839 ↗
Masahiko Watanabe · 1 shared paper, 2019 · strength 0.08
- Paper Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. DOI 10.1111/cas.14134 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.